SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001370053-21-000041
Filing Date
2021-05-04
Accepted
2021-05-04 16:22:58
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q anab-20210331.htm   iXBRL 10-Q 1318219
2 EX-31.1 anab-3312021x10qxexx311.htm EX-31.1 8529
3 EX-31.2 anab-3312021x10qxexx312.htm EX-31.2 8394
4 EX-32.1 anab-3312021x10qxexx321.htm EX-32.1 5055
5 EX-32.2 anab-3312021x10qxexx322.htm EX-32.2 4908
11 anab-20210331_g1.jpg GRAPHIC 124767
  Complete submission text file 0001370053-21-000041.txt   5924013

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20210331.xsd EX-101.SCH 37285
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20210331_cal.xml EX-101.CAL 56621
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20210331_def.xml EX-101.DEF 175705
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20210331_lab.xml EX-101.LAB 457113
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20210331_pre.xml EX-101.PRE 280488
12 EXTRACTED XBRL INSTANCE DOCUMENT anab-20210331_htm.xml XML 959114
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37985 | Film No.: 21888823
SIC: 2834 Pharmaceutical Preparations